Fulcrum Therapeutics, Inc.FULCNASDAQ
Loading
Total Costs & Expenses Over TimeContracting
Percentile Rank50
3Y CAGR-10.7%
5Y CAGR+1.1%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
-10.7%/yr
vs +37.3%/yr prior
5Y CAGR
+1.1%/yr
Recent deceleration
Acceleration
-47.9pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$84.77M-16.8%
2024$101.90M-10.2%
2023$113.47M-4.6%
2022$118.90M+18.6%
2021$100.22M+24.6%
2020$80.43M+37.2%
2019$58.63M+75.0%
2018$33.50M+45.7%
2017$22.99M-